ADP Reports Private Payrolls Rise by 109000 in April Exceeding Expectations Signals Stable Labor Market Wall Streets Private Investments Increasingly Rely on InHouse Insurers as Buyers Micron Stock Surges to Milestone as UBS Boosts Price Target on Strong Memory Chip Demand Elon Musks Legal Defeat Against OpenAI What It Means for the AI Race JetBlue and United Airlines Launch Reciprocal Loyalty Perks for TrueBlue and MileagePlus Members The Feds Path to Rate Cuts Narrows as CostofLiving Pressures Intensify SLB Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Despite Stable Revenue IDT Q1 2026 Earnings Mixed Quarter as Earnings Miss Estimates but Stock Edges Higher ELBM Q4 2025 Earnings Significant EPS Miss Amid Operational Challenges SLS Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue Stock Rises 57 FGBI Q1 2026 Earnings EPS Surges 96 Above Estimates Stock Gains 4 LFMD Q1 2026 Earnings EPS Surprise Lifts Sentiment Despite Disclosed Revenue Uncertainty TFI International TFII Advances 193 Testing Key Resistance After Support Hold Carlyle Credit Income Fund Series D Preferred Shares CCID Hold Steady at 2535 Abundia Global Impact Group AGIG Surges 446 Testing Resistance at 123 TrustCo Bank Corp TRST Slips Slightly Support Test in Focus MIND CTI MNDO Shows Resilience with Modest Gain Amid Narrow Trading Range Ribbon Communications Q1 2026 Earnings Narrowing Loss Beats Estimates Shares Rally Solaris Resources Inc SLSR Q1 2026 Earnings Net Loss Narrows as Exploration Ramps Stock Slips Global Self Storage Inc SELF Q4 2025 Earnings EPS Falls Short of Estimates as Revenue Details Remain Undisclosed IZEA Q4 2025 Earnings EPS Misses Estimates as Stock Rises on Potential Turnaround Canada Goose GOOS Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Lower MBX Biosciences Inc MBX Q1 2026 Earnings EPS Beat as PreRevenue Biotech Advances Pipeline UK Exports to US Plunge 25 Following Trumps Liberation Day Tariffs Trade Deficit Emerges WAVE Q1 2026 Earnings EPS Surprises to the Upside Amid Limited Revenue Visibility PMV Pharmaceuticals PMVP Slips to 126 as Cautious Trading Puts Support to the Test